Lumito AB (publ) (“Lumito” or the “Company”) has received an order from a European university hospital. The order, valued at approximately EUR 4,000, is the Company’s first order outside the Nordic region since its commercial launch and thus marks an initial commercial step into a new geographical market.
The order includes a SCIZYS Erbium Kit as well as scans through Scan-as-a-Service. The customer conducts cancer-related research at a university hospital and will use Lumito’s solution to evaluate the technology’s potential to provide increased sensitivity and improved tissue analysis compared with existing methods.
The order is a concrete result of Lumito’s work to evaluate AI-based methods for lead generation. The order confirms the Company’s ability to identify, engage with and convert identified business opportunities into commercial transactions.
"Our first commercial order outside the Nordic region is an encouraging step for Lumito. The order confirms both the international interest in SCIZYS and our ability to convert business opportunities into commercial transactions”, says Sanna Wallenborg, CEO of Lumito.